Can diet and exercise improve melanoma outcomes?
NCT ID NCT04778449
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how lifestyle factors like diet, exercise, mental health, and social support affect quality of life and outcomes in people with melanoma. Researchers will follow 5,000 participants over time using surveys and medical records. The goal is to gather knowledge that could guide future lifestyle-based clinical trials and help doctors better counsel their patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help design future trials on lifestyle changes to improve melanoma patient outcomes and guide doctors in counseling patients.
- What could go wrong
- This is an observational study, not a treatment trial. It only looks for links between lifestyle and outcomes, so it cannot prove cause and effect.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS MELANOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- E-Learning could sharpen Doctors' eye for skin cancer
- Can a new drug tame advanced solid tumors?
- Can a short Pre-Surgery immunotherapy course replace Long-Term adjuvant treatment for melanoma?
- Can a single tracer light up cancer's first stop? a trial puts a hybrid dye-and-radioactive marker to the test.
- Could a Two-Drug combo reawaken the immune system against resistant cancers?
- Could starting immunotherapy earlier improve outcomes for High-Risk melanoma?